Company
United StatesPublic company, NYSE: ABBVAbbVie Inc. (NYSE: ABBV), Wyandotte, MI – FDA Inspections
Inspection records and compliance data for AbbVie Inc. in Wyandotte, Michigan. 6 FDA inspections on record, last inspected May 12, 2023. Publicly traded as NYSE: ABBV.
Company Profile
This profile covers AbbVie Inc. based in Wyandotte, Michigan, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 0
- NAI
- 6
- Form 483s
- 0
- Warning letters
- 0
First inspected January 16, 2009. Last inspected May 12, 2023.
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 12, 2023 | NAI | Human Drugs · Drug Quality Assurance | 1208091 |
| February 16, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1045001 |
| July 13, 2016 | NAI | Human Drugs · Drug Quality Assurance | 977539 |
| August 9, 2012 | NAI | Human Drugs · Drug Quality Assurance | 794178 |
| October 28, 2010 | NAI | Human Drugs · Drug Quality Assurance | 695187 |
| January 16, 2009 | NAI | Human Drugs · Drug Quality Assurance | 557386 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
AbbVie Inc.
Stock ticker
ABBV
Exchange
NYSE
Share price
$288.70
Market cap
$510.3B
Price as of
November 6, 2026
FEI Number
3010166391
Address
1609 Biddle Ave Bldg 63, Wyandotte, Michigan 48192, United States
Country
United States
ID: cfa8bee4-fcef-42ed-ae96-bcfb37c75051